Is EGO a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Skouries ramp-up, with revenue (ttm) at ~$2.0B. The bear case rests on eldorado carries meaningful execution risk on two large capital projects at once, and Skouries first concentrate has already slipped about a quarter. Analysts covering it are spread from $33.00 to $54.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Eldorado carries meaningful execution risk on two large capital projects at once, and Skouries first concentrate has already slipped about a quarter. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $33.00, +5.8% from the $31.18 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Skouries ramp-up. Skouries is a world-class copper-gold asset in Greece that is guided to first concentrate in early Q3 2026 and commercial production by Q4 2026. The most optimistic analyst target on EGO is $54.00, +73.2% from the $31.18 price. That figure is only reachable if this thesis works close to its best case.

Eldorado carries meaningful execution risk on two large capital projects at once, and Skouries first concentrate has already slipped about a quarter. Heavy capital spending (roughly $318 million in Q1 2026) has kept free cash flow negative and pushed total debt to around $1.24 billion. The company operates in Turkey and Greece, which add geopolitical, permitting, and currency risk, and the Foran deal introduces integration risk plus new copper-price exposure. Above all, the stock is highly sensitive to the gold price, so a sharp pullback in gold would hit earnings and the share price hard. The most pessimistic published target is $33.00, +5.8% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Eldorado Gold Corp (NYSE and TSX: EGO) is a Vancouver-based mid-tier precious-metals producer with four operating mines: Kisladag and Efemcukuru in Turkey, the Lamaque Complex in Q

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Skouries ramp-up) stalling in the reported numbers rather than in the narrative, the risk above (eldorado carries meaningful execution risk on two large capital projects at once, and Skouries first concentrate has already slipped about a quarter) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

Eldorado Gold is a mid-tier mining company that produces gold, and increasingly copper, from operations in Turkey, Canada, and Greece. Its main assets include Kisladag, Efemcukuru, the Lamaque Complex, Olympias, and the Skouries and McIlvenna Bay growth projects.

It is primarily a gold producer today, but it is transitioning toward gold-copper. The Skouries project in Greece and the 2026 Foran/McIlvenna Bay acquisition in Canada both add significant copper production, so EGO is becoming a hybrid gold-copper miner.

For 2026 the company guides to roughly 490,000 to 590,000 ounces of gold, weighted toward the second half. It produced about 100,000 ounces in Q1 2026 and targets roughly 40 percent production growth in 2027 as Skouries ramps up.